- Home
- LXRX vs CLMB Comparison
LXRX vs CLMB Comparison
Compare LXRX & CLMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- CLMB
- Stock Information
- Founded
- LXRX 1995
- CLMB 1982
- Country
- LXRX United States
- CLMB United States
- Employees
- LXRX N/A
- CLMB N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- CLMB Retail: Computer Software & Peripheral Equipment
- Sector
- LXRX Health Care
- CLMB Technology
- Exchange
- LXRX Nasdaq
- CLMB Nasdaq
- Market Cap
- LXRX 352.5M
- CLMB 417.8M
- IPO Year
- LXRX 2000
- CLMB N/A
- Fundamental
- Price
- LXRX $0.75
- CLMB $135.95
- Analyst Decision
- LXRX Buy
- CLMB Buy
- Analyst Count
- LXRX 2
- CLMB 1
- Target Price
- LXRX $6.00
- CLMB $136.00
- AVG Volume (30 Days)
- LXRX 4.9M
- CLMB 33.5K
- Earning Date
- LXRX 11-12-2024
- CLMB 10-30-2024
- Dividend Yield
- LXRX N/A
- CLMB 0.51%
- EPS Growth
- LXRX N/A
- CLMB 39.90
- EPS
- LXRX N/A
- CLMB 3.68
- Revenue
- LXRX $5,229,000.00
- CLMB $410,631,000.00
- Revenue This Year
- LXRX $886.38
- CLMB $21.18
- Revenue Next Year
- LXRX $181.58
- CLMB $16.80
- P/E Ratio
- LXRX N/A
- CLMB $36.81
- Revenue Growth
- LXRX 886.60
- CLMB 22.89
- 52 Week Low
- LXRX $0.62
- CLMB $48.67
- 52 Week High
- LXRX $3.73
- CLMB $142.50
- Technical
- Relative Strength Index (RSI)
- LXRX 38.05
- CLMB 59.95
- Support Level
- LXRX $0.72
- CLMB $125.12
- Resistance Level
- LXRX $0.85
- CLMB $138.10
- Average True Range (ATR)
- LXRX 0.09
- CLMB 5.96
- MACD
- LXRX 0.03
- CLMB -1.05
- Stochastic Oscillator
- LXRX 33.10
- CLMB 73.27
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.
About CLMB Climb Global Solutions Inc.
Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The Company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.